252 related articles for article (PubMed ID: 19486026)
1. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.
Verma S; Vanryzin C; Sinaii N; Kim MS; Nieman LK; Ravindran S; Calis KA; Arlt W; Ross RJ; Merke DP
Clin Endocrinol (Oxf); 2010 Apr; 72(4):441-7. PubMed ID: 19486026
[TBL] [Abstract][Full Text] [Related]
2. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
[TBL] [Abstract][Full Text] [Related]
5. Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
Merke DP; Mallappa A; Arlt W; Brac de la Perriere A; Lindén Hirschberg A; Juul A; Newell-Price J; Perry CG; Prete A; Rees DA; Reisch N; Stikkelbroeck N; Touraine P; Maltby K; Treasure FP; Porter J; Ross RJ
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2063-e2077. PubMed ID: 33527139
[TBL] [Abstract][Full Text] [Related]
6. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
7. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
8. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
[TBL] [Abstract][Full Text] [Related]
9. Modified-release hydrocortisone to provide circadian cortisol profiles.
Debono M; Ghobadi C; Rostami-Hodjegan A; Huatan H; Campbell MJ; Newell-Price J; Darzy K; Merke DP; Arlt W; Ross RJ
J Clin Endocrinol Metab; 2009 May; 94(5):1548-54. PubMed ID: 19223520
[TBL] [Abstract][Full Text] [Related]
10. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
Sarafoglou K; Zimmerman CL; Gonzalez-Bolanos MT; Willis BA; Brundage R
J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Charmandari E; Johnston A; Brook CG; Hindmarsh PC
J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
[TBL] [Abstract][Full Text] [Related]
12. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
El-Maouche D; Merke DP; Vogiatzi MG; Chang AY; Turcu AF; Joyal EG; Lin VH; Weintraub L; Plaunt MR; Mohideen P; Auchus RJ
J Clin Endocrinol Metab; 2020 Aug; 105(8):2771-8. PubMed ID: 32589738
[TBL] [Abstract][Full Text] [Related]
13. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
[TBL] [Abstract][Full Text] [Related]
14. Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia.
Karunasena N; Margetson DN; Neal G; Whitaker MJ; Ross RJ
Eur J Endocrinol; 2017 Apr; 176(4):405-411. PubMed ID: 28100629
[TBL] [Abstract][Full Text] [Related]
15. Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone.
Espiard S; McQueen J; Sherlock M; Ragnarsson O; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Skrtic S; Wahlberg J; Stewart PM; Johannsson G
J Clin Endocrinol Metab; 2021 Mar; 106(3):814-825. PubMed ID: 33236103
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
[TBL] [Abstract][Full Text] [Related]
17. A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
Besci Ö; Erbaş İM; Küme T; Acinikli KY; Abacı A; Böber E; Demir K
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):145-152. PubMed ID: 34866371
[TBL] [Abstract][Full Text] [Related]
18. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS; Ljubicic ML; Main KM; Andersson AM; Petersen JH; Frederiksen H; Duno M; Johannsen TH; Juul A
Horm Res Paediatr; 2020; 93(4):226-238. PubMed ID: 33017824
[TBL] [Abstract][Full Text] [Related]
19. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[TBL] [Abstract][Full Text] [Related]
20. Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy.
German A; Suraiya S; Tenenbaum-Rakover Y; Koren I; Pillar G; Hochberg Z
J Clin Endocrinol Metab; 2008 Dec; 93(12):4707-10. PubMed ID: 18782876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
